T. Rowe Price Associates
CORZ icon

T. Rowe Price Associates’s Core Scientific CORZ Stock Holding History

T. Rowe Price Associates’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$159M Buy
6,215,115
+5,508,420
+779% +$130M 0.02% 572
2026
Q1 		$10.6M Buy
706,695
+54,470
+8% +$929K ﹤0.01% 1204
2025
Q4 		$9.5M Sell
652,225
-3,705,717
-85% -$64.6M ﹤0.01% 1243
2025
Q3 		$78.2M Buy
4,357,942
+4,123,005
+1,755% +$60.5M 0.01% 675
2025
Q2 		$4.01M Buy
234,937
+58,962
+34% +$590K ﹤0.01% 1343
2025
Q1 		$1.27M Buy
175,975
+20,058
+13% +$228K ﹤0.01% 1825
2024
Q4 		$2.19M Buy
155,917
+50,758
+48% +$750K ﹤0.01% 1605
2024
Q3 		$1.25M Buy
105,159
+48,463
+85% +$502K ﹤0.01% 1877
2024
Q2 		$0 Buy
+56,696
New +$290K ﹤0.01% 2943

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

T. Rowe Price Associates's CORZ Position: Q2 2026 in Review

T. Rowe Price Associates increased its Core Scientific (CORZ) stake by 779% in Q2 2026, buying an estimated $130M and bringing the position to 6,215,115 shares worth $159M. The position accounts for 0.02% of the portfolio, ranked #572.

T. Rowe Price Associates first reported a position in CORZ in Q2 2024 and has held it in 9 quarters since. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • T. Rowe Price Associates held 6,215,115 shares of Core Scientific worth $159M as of Q2 2026.
  • T. Rowe Price Associates bought 5,508,420 Core Scientific shares in Q2 2026, an estimated $130M.
  • Core Scientific made up 0.02% of T. Rowe Price Associates's portfolio in Q2 2026, its #572 holding.
  • T. Rowe Price Associates first reported a position in Core Scientific in Q2 2024 and has held it in 9 quarters since.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.